Global Anti-Vascular Endothelial Growth Factor Therapeutics Market Size study, by Device (Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration), by Product (Eylea, Lucentis, Beovu), and Regional Forecasts 2021-2027
Global Anti-Vascular Endothelial Growth Factor Therapeutics Market is valued approximately at USD 11.67 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 0.5% over the forecast period 2021-2027. Anti-vascular endothelial growth factor is a regulator of the angiogenesis during the growth and development in disease states such as cancer, diabetes, and macular degeneration. The global anti-vascular endothelial growth factor therapeutics market is being driven by growth in prevalence of various ophthalmic diseases such as macular edema, diabetic retinopathy, retinal vein occlusion, and Age-related Macular Degeneration (AMD) along with rise in geriatric population. Furthermore, initiatives by market players such as product launches and research technological advancements, will provide new opportunities for the global anti-vascular endothelial growth factor therapeutics industry. For instance, according to the report of WHO published in 2021, about 196 million people have been affected by AMD across the world, which also includes around 10.4 million cases with a moderate to severe vision impairment. As a result, increased in ophthalmic diseases will necessitate the use will serve as a catalyst for the Anti-Vascular Endothelial Growth Factor Therapeutics industry in the future. However, low screening rates and the rates of diagnostic of diabetic retinopathy in developing nations, may impede market growth over the forecast period of 2021-2027.
Asia Pacific, North America, Europe, Latin America, and Rest of the World are the key regions considered for the regional analysis of global anti-vascular endothelial growth factor therapeutics market. High disease prevalence, rising government measures, and technological advancements makes North America the leading region across the world in terms of market share. Whereas Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to increase in penetration of anti-VEGF products, rising disposable income, and growing consumer awareness in the region.
Major market player included in this report are:
Hoffmann-la roche ltd
Bayer ag
Regeneron pharmaceuticals inc.
Novartis ag
Biogen
Coherus Biosciences
Pfizer Inc.
Viatris Inc
Amgen
Eli Lilly and company
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Device:
Macular Edema
Diabetic Retinopathy
Retinal Vein Occlusion
Age-related Macular Degeneration
By Product:
Eylea
Lucentis
Beovu
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.
Target Audience of the Global Anti-Vascular Endothelial Growth Factor Therapeutics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Asia Pacific, North America, Europe, Latin America, and Rest of the World are the key regions considered for the regional analysis of global anti-vascular endothelial growth factor therapeutics market. High disease prevalence, rising government measures, and technological advancements makes North America the leading region across the world in terms of market share. Whereas Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to increase in penetration of anti-VEGF products, rising disposable income, and growing consumer awareness in the region.
Major market player included in this report are:
Hoffmann-la roche ltd
Bayer ag
Regeneron pharmaceuticals inc.
Novartis ag
Biogen
Coherus Biosciences
Pfizer Inc.
Viatris Inc
Amgen
Eli Lilly and company
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Device:
Macular Edema
Diabetic Retinopathy
Retinal Vein Occlusion
Age-related Macular Degeneration
By Product:
Eylea
Lucentis
Beovu
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.
Target Audience of the Global Anti-Vascular Endothelial Growth Factor Therapeutics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Anti-Vascular Endothelial Growth Factor Therapeutics Market, by Region, 2019-2027 (USD Billion)
1.2.2. Anti-Vascular Endothelial Growth Factor Therapeutics Market, by Disease , 2019-2027 (USD Billion)
1.2.3. Anti-Vascular Endothelial Growth Factor Therapeutics Market, by Product , 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPEUTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPEUTICS MARKET DYNAMICS
3.1. Anti-Vascular Endothelial Growth Factor Therapeutics MarketImpact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Rise in prevalence of various ophthalmic diseases
3.1.1.2. Rapid growth in geriatric population
3.1.2. Market Restraint
3.1.2.1. low screening and diagnostic rates of diabetic retinopathy in developing nations
3.1.3. Market Opportunities
3.1.3.1. product launches and research technological advancements
CHAPTER 4. GLOBAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPEUTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPEUTICS MARKET, BY DISEASE
5.1. Market Snapshot
5.2. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by Disease , Performance - Potential Analysis
5.3. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market Estimates & Forecasts by Disease 2018-2027 (USD Billion)
5.4. Anti-Vascular Endothelial Growth Factor Therapeutics Market, Sub Segment Analysis
5.4.1. Macular Edema
5.4.2. Diabetic Retinopathy
5.4.3. Retinal Vein Occlusion
5.4.4. Age-related Macular Degeneration
CHAPTER 6. GLOBAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPEUTICS MARKET, BY PRODUCT
a. Market Snapshot
6.1. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by Product, Performance - Potential Analysis
6.2. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market Estimates & Forecasts by Product 2018-2027 (USD Billion)
6.3. Anti-Vascular Endothelial Growth Factor Therapeutics Market, Sub Segment Analysis
6.3.1. Eylea
6.3.2. Lucentis
6.3.3. Beovu
CHAPTER 7. GLOBAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPEUTICS MARKET, REGIONAL ANALYSIS
7.1. Anti-Vascular Endothelial Growth Factor Therapeutics Market, Regional Market Snapshot
7.2. North America Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.2.1. U.S. Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.2.1.1. Disease breakdown estimates & forecasts, 2018-2027
7.2.1.2. Product breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.3. Europe Anti-Vascular Endothelial Growth Factor Therapeutics Market Snapshot
7.3.1. U.K. Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.3.2. Germany Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.3.3. France Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.3.4. Spain Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.3.5. Italy Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.3.6. Rest of Europe Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.4. Asia-Pacific Anti-Vascular Endothelial Growth Factor Therapeutics Market Snapshot
7.4.1. China Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.4.2. India Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.4.3. Japan Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.4.4. Australia Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.4.5. South Korea Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.4.6. Rest of Asia Pacific Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.5. Latin America Anti-Vascular Endothelial Growth Factor Therapeutics Market Snapshot
7.5.1. Brazil Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.5.2. Mexico Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.6. Rest of The World Anti-Vascular Endothelial Growth Factor Therapeutics Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Hoffmann-la roche ltd
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Bayer ag
8.2.3. Regeneron pharmaceuticals inc.
8.2.4. Novartis ag
8.2.5. Biogen
8.2.6. Coherus Biosciences
8.2.7. Pfizer Inc.
8.2.8. Viatris Inc
8.2.9. Amgen
8.2.10. Eli Lilly and company
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Anti-Vascular Endothelial Growth Factor Therapeutics Market, by Region, 2019-2027 (USD Billion)
1.2.2. Anti-Vascular Endothelial Growth Factor Therapeutics Market, by Disease , 2019-2027 (USD Billion)
1.2.3. Anti-Vascular Endothelial Growth Factor Therapeutics Market, by Product , 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPEUTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPEUTICS MARKET DYNAMICS
3.1. Anti-Vascular Endothelial Growth Factor Therapeutics MarketImpact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Rise in prevalence of various ophthalmic diseases
3.1.1.2. Rapid growth in geriatric population
3.1.2. Market Restraint
3.1.2.1. low screening and diagnostic rates of diabetic retinopathy in developing nations
3.1.3. Market Opportunities
3.1.3.1. product launches and research technological advancements
CHAPTER 4. GLOBAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPEUTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPEUTICS MARKET, BY DISEASE
5.1. Market Snapshot
5.2. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by Disease , Performance - Potential Analysis
5.3. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market Estimates & Forecasts by Disease 2018-2027 (USD Billion)
5.4. Anti-Vascular Endothelial Growth Factor Therapeutics Market, Sub Segment Analysis
5.4.1. Macular Edema
5.4.2. Diabetic Retinopathy
5.4.3. Retinal Vein Occlusion
5.4.4. Age-related Macular Degeneration
CHAPTER 6. GLOBAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPEUTICS MARKET, BY PRODUCT
a. Market Snapshot
6.1. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by Product, Performance - Potential Analysis
6.2. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market Estimates & Forecasts by Product 2018-2027 (USD Billion)
6.3. Anti-Vascular Endothelial Growth Factor Therapeutics Market, Sub Segment Analysis
6.3.1. Eylea
6.3.2. Lucentis
6.3.3. Beovu
CHAPTER 7. GLOBAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPEUTICS MARKET, REGIONAL ANALYSIS
7.1. Anti-Vascular Endothelial Growth Factor Therapeutics Market, Regional Market Snapshot
7.2. North America Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.2.1. U.S. Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.2.1.1. Disease breakdown estimates & forecasts, 2018-2027
7.2.1.2. Product breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.3. Europe Anti-Vascular Endothelial Growth Factor Therapeutics Market Snapshot
7.3.1. U.K. Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.3.2. Germany Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.3.3. France Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.3.4. Spain Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.3.5. Italy Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.3.6. Rest of Europe Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.4. Asia-Pacific Anti-Vascular Endothelial Growth Factor Therapeutics Market Snapshot
7.4.1. China Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.4.2. India Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.4.3. Japan Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.4.4. Australia Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.4.5. South Korea Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.4.6. Rest of Asia Pacific Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.5. Latin America Anti-Vascular Endothelial Growth Factor Therapeutics Market Snapshot
7.5.1. Brazil Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.5.2. Mexico Anti-Vascular Endothelial Growth Factor Therapeutics Market
7.6. Rest of The World Anti-Vascular Endothelial Growth Factor Therapeutics Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Hoffmann-la roche ltd
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Bayer ag
8.2.3. Regeneron pharmaceuticals inc.
8.2.4. Novartis ag
8.2.5. Biogen
8.2.6. Coherus Biosciences
8.2.7. Pfizer Inc.
8.2.8. Viatris Inc
8.2.9. Amgen
8.2.10. Eli Lilly and company
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
LIST OF TABLES
TABLE 2. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market, report scope
TABLE 3. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 4. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by Disease 2018-2027 (USD Billion)
TABLE 5. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by Product 2018-2027 (USD Billion)
TABLE 6.
TABLE 7. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. U.S. Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 24. U.S. Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. U.S. Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 26. Canada Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 27. Canada Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. Canada Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 29. UK Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 30. UK Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. UK Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 32. Germany Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 33. Germany Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. Germany Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 35. France Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 36. France Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. France Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 38. Spain Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 39. Spain Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. Spain Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 41. Italy Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 42. Italy Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. Italy Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 44. ROE Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 45. ROE Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. ROE Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 47. China Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 48. China Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. China Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 50. India Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 51. India Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. India Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 53. Japan Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 54. Japan Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. Japan Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 56. Australia Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 57. Australia Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 58. Australia Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 59. South Korea Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 60. South Korea Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 61. South Korea Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 62. ROPAC Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 63. ROPAC Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 64. ROPAC Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 65. Brazil Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 66. Brazil Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 67. Brazil Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 68. Mexico Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 69. Mexico Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 70. Mexico Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 71. ROLA Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 72. ROLA Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 73. ROLA Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 74. ROW Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 75. ROW Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 76. ROW Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 77. List of secondary sources used in the study of global Anti-Vascular Endothelial Growth Factor Therapeutics Market.
TABLE 78. List of primary sources used in the study of global Anti-Vascular Endothelial Growth Factor Therapeutics Market.
TABLE 79. Years considered for the study.
TABLE 80. Exchange rates considered.
TABLE 2. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market, report scope
TABLE 3. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 4. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by Disease 2018-2027 (USD Billion)
TABLE 5. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by Product 2018-2027 (USD Billion)
TABLE 6.
TABLE 7. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. U.S. Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 24. U.S. Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. U.S. Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 26. Canada Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 27. Canada Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. Canada Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 29. UK Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 30. UK Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. UK Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 32. Germany Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 33. Germany Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. Germany Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 35. France Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 36. France Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. France Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 38. Spain Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 39. Spain Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. Spain Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 41. Italy Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 42. Italy Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. Italy Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 44. ROE Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 45. ROE Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. ROE Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 47. China Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 48. China Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. China Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 50. India Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 51. India Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. India Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 53. Japan Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 54. Japan Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. Japan Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 56. Australia Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 57. Australia Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 58. Australia Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 59. South Korea Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 60. South Korea Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 61. South Korea Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 62. ROPAC Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 63. ROPAC Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 64. ROPAC Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 65. Brazil Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 66. Brazil Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 67. Brazil Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 68. Mexico Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 69. Mexico Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 70. Mexico Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 71. ROLA Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 72. ROLA Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 73. ROLA Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 74. ROW Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 75. ROW Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 76. ROW Anti-Vascular Endothelial Growth Factor Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 77. List of secondary sources used in the study of global Anti-Vascular Endothelial Growth Factor Therapeutics Market.
TABLE 78. List of primary sources used in the study of global Anti-Vascular Endothelial Growth Factor Therapeutics Market.
TABLE 79. Years considered for the study.
TABLE 80. Exchange rates considered.
LIST OF FIGURES
FIG 1. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market, research methodology
FIG 2. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market, key trends 2020
FIG 5. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market, growth prospects 2021-2027
FIG 6. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market, porters 5 force model
FIG 7. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market, pest analysis
FIG 8. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market, value chain analysis
FIG 9. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, 2018 & 2027 (USD Billion)
FIG 15. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, 2018 & 2027 (USD Billion)
FIG 16. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, 2018 & 2027 (USD Billion)
FIG 17. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market, regional snapshot 2018 & 2027
FIG 18. North America Anti-Vascular Endothelial Growth Factor Therapeutics Market 2018 & 2027 (USD Billion)
FIG 19. Europe Anti-Vascular Endothelial Growth Factor Therapeutics Market 2018 & 2027 (USD Billion)
FIG 20. Asia-Pacific Anti-Vascular Endothelial Growth Factor Therapeutics Market 2018 & 2027 (USD Billion)
FIG 21. Latin America Anti-Vascular Endothelial Growth Factor Therapeutics Market 2018 & 2027 (USD Billion)
FIG 22. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market, company market share analysis (2020)
FIG 1. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market, research methodology
FIG 2. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market, key trends 2020
FIG 5. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market, growth prospects 2021-2027
FIG 6. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market, porters 5 force model
FIG 7. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market, pest analysis
FIG 8. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market, value chain analysis
FIG 9. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, 2018 & 2027 (USD Billion)
FIG 15. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, 2018 & 2027 (USD Billion)
FIG 16. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market by segment, 2018 & 2027 (USD Billion)
FIG 17. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market, regional snapshot 2018 & 2027
FIG 18. North America Anti-Vascular Endothelial Growth Factor Therapeutics Market 2018 & 2027 (USD Billion)
FIG 19. Europe Anti-Vascular Endothelial Growth Factor Therapeutics Market 2018 & 2027 (USD Billion)
FIG 20. Asia-Pacific Anti-Vascular Endothelial Growth Factor Therapeutics Market 2018 & 2027 (USD Billion)
FIG 21. Latin America Anti-Vascular Endothelial Growth Factor Therapeutics Market 2018 & 2027 (USD Billion)
FIG 22. Global Anti-Vascular Endothelial Growth Factor Therapeutics Market, company market share analysis (2020)
